Pharma BD Deal Intelligence

Astellas Pharma Inc. / Ganymed Pharmaceuticals

2016 · Acquisition/Merger · $1.4B · Complete

Announcement Sentiment

75

Strongly positive

Outcome Score

81

Worked — the deal delivered on its rationale.

Astellas acquired Ganymed for $1.4B for oncology.

Key facts

Announced Oct 28, 2016
Closed Dec 20, 2016
Deal value $1.4B
Deal type Acquisition/Merger
Therapeutic area Oncology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals